1 Feb 2012

UCB and Astellas announce agreement to jointly develop and commercialize Cimzia® (certolizumab pegol) in Japan

Read More
27 Jan 2012

Transparency Notification of Wellington management Company LLP

Read More
26 Jan 2012

Acquisition of own shares in the framework of employees’ long-term incentive plans

Read More
25 Jan 2012

UCB announces FDA approval for Keppra® in infants and children from one month of age with partial onset seizures

Read More
23 Jan 2012

NYSE Euronext Brussels grants UCB the Best BEL 20 Performer Award 2011

Read More
19 Jan 2012

Acquisition of own shares in the framework of employees’ long-term incentive plans

Read More
13 Jan 2012

Otsuka Pharmaceutical and UCB focus collaboration in the area of Central Nervous System (CNS) disorders

Read More
12 Jan 2012

Acquisition of own shares in the framework of employees’ long-term incentive plans

Read More
9 Jan 2012

UCB announces positive top-line results from phase II open-label pilot study of Vimpat® (lacosamide) in primary generalized tonic-clonic seizures

Read More
5 Jan 2012

Acquisition of own shares in the framework of employees’ long-term incentive plans

Read More
Subscribe to